See the DrugPatentWatch profile for Repaglinide
What is the usual repaglinide starting dose?
Repaglinide dosing depends on whether you are starting treatment for the first time or switching from another diabetes medicine. Typical starting doses are set low and then adjusted based on blood glucose response.
Common starting practice is 0.5 mg taken before meals (often before the two main meals at first, then adjusted).
How should repaglinide be taken (timing with food)?
Repaglinide is taken by mouth shortly before meals. Users generally take it:
- Within 15–30 minutes before eating
- Only on days when a meal is planned
If a meal is skipped, a dose is usually skipped as well to lower hypoglycemia risk.
How is the dose adjusted?
The dose is usually titrated based on glucose readings (including how low blood sugar goes after meals). Adjustment is typically gradual, moving stepwise and rechecking response over subsequent days.
Clinicians generally increase the dose if glucose remains above target and reduce it if there are low-glucose episodes.
What is the usual maximum dose?
Repaglinide doses are often limited by a daily maximum and by the highest per-meal dose set in the prescribing information for safety. In practice, many regimens cap the total amount per day rather than letting dosing rise indefinitely.
If you tell me your dose form (tablet strength) and what you were prescribed (e.g., “1 mg before meals”), I can help you verify the schedule and whether it fits common titration patterns.
What if you have kidney or liver problems?
Dose requirements can change with kidney or liver impairment, because repaglinide exposure and hypoglycemia risk can increase. People with reduced kidney function or significant liver disease often need more conservative dosing and closer monitoring.
What side effects are most important for dosing?
The main dosing-related concern is hypoglycemia (low blood sugar), especially if:
- Doses are taken without eating
- Doses are increased too quickly
- Meals are smaller than usual
- Other glucose-lowering medicines are also used
If you’re experiencing dizziness, sweating, confusion, or shaking, that may signal low blood sugar and you should check your glucose and treat it promptly.
Interactions that can change repaglinide dosing needs
Some medicines can raise or lower repaglinide levels and increase hypoglycemia or reduce effectiveness. If you list your other diabetes drugs (and key non-diabetes meds), I can point out interaction scenarios that commonly affect how tightly repaglinide dosing must be managed.
Quick safety check
If you answer these, I can give a more precise dosing explanation aligned to typical prescribing patterns:
1) What dose strength are your tablets (0.5 mg, 1 mg, etc.)?
2) What regimen was prescribed (before which meals, and how many times daily)?
3) Are you starting repaglinide or switching from another diabetes medication?
4) Any kidney or liver disease, or frequent low blood sugar?